Kan-Mitchell et al., 1985 - Google Patents
Cytotoxic activity of human pulmonary alveolar macrophagesKan-Mitchell et al., 1985
- Document ID
- 2949769510402224473
- Author
- Kan-Mitchell J
- Hengst J
- Kempf R
- Rothbart R
- Simons S
- Brooker A
- Kortes V
- Mitchell M
- Publication year
- Publication venue
- Cancer research
External Links
Snippet
The functions of human pulmonary alveolar macrophages (PAMs) have been relatively little studied compared with those of their circulating counterparts, blood monocytes. This study examined the ability of human PAMs to kill primary human tumor cell cultures and control …
- 230000001472 cytotoxic 0 title abstract description 51
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Landy et al. | Humoral and cellular aspects of the immune response to the somatic antigen of Salmonella enteritidis | |
Parkhouse et al. | Inhibition of spleen cell DNA synthesis by autologous macrophages | |
Tagliabue et al. | Natural cytotoxicity of mouse monocytes and macrophages | |
Hungerford et al. | Chromosome studies in human leukemia. III. Acute granulocytic leukemia | |
Avinoach et al. | γ/δ T-cell lymphoma involving the subcutaneous tissue and associated with a hemophagocytic syndrome | |
Zwadlo-Klarwasser et al. | Glucocorticoid-induced appearance of the macrophage subtype RM 3/1 in peripheral blood of man | |
Spahn et al. | Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study | |
Claman | Human Thymus Cell Cultures—Evidence for Two Functional Populations. | |
Kan-Mitchell et al. | Cytotoxic activity of human pulmonary alveolar macrophages | |
Spiteri et al. | Alveolar macrophage-induced suppression of peripheral blood mononuclear cell responsiveness is reversed by in vitro allergen exposure in bronchial asthma | |
Vonderheid et al. | Extracorporeal photopheresis in psoriasis vulgaris: clinical and immunologic observations | |
McLelland et al. | Current controversies | |
Pirttikangas et al. | Propofol infusion anaesthesia and immune response in minor surgery | |
Olson et al. | Levamisole: a new treatment for recurrent aphthous stomatitis | |
Baldessarini et al. | Adenosylmethionine elevation in leukemic white blood cells | |
Scheibenbogen et al. | Interferon-Gamma-lnduced Expression of Tissue Factor Activity during Human Monocyte to Macrophage Maturation | |
Shinomiya et al. | Activated killer monocytes: Preclinical model systems | |
Yang et al. | Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response. | |
Amsden et al. | Etiology of the liver granulomatous response in Schistosoma mansoni-infected athymic nude mice | |
Okubo et al. | Production of tumor necrosis factor‐α by alveolar macrophages of lung cancer patients | |
Sauvaigo et al. | Autonomous proliferation of mewo human melanoma cell lines in serum‐free medium: Secretion of growth‐stimulating activities | |
CN114292813B (en) | Culture medium formulations for activating the global anti-tumor immune system and methods for preparing agonist-activated global immune effector cells | |
Dalakas | Inflammatory myopathies | |
Kawabori et al. | Existence of c-kit receptor-positive, tryptase-negative, IgE-negative cells in human allergic nasal mucosa: a candidate for mast cell progenitor | |
KR100392996B1 (en) | Cell growth regulators |